ICYMI As mRNA-based medicines move toward clinical development stages, the question of defining quality attributes and analytical testing procedures become ever more important. As part of an ongoing series discussing mRNA manufacturing, Nate Spangler looks at the state of those elements and what the future could hold for implementation. https://ald.bio/3UOUzGC
Aldevron’s Post
More Relevant Posts
-
⬇ Good things just got even better! ⬇ ✔ Expertise and excellence in plasmid manufacturing. ✔ Expertise and excellence in IVT. ✔ Expertise and excellence in analytics. ✔ Streamlined manufacturing. ✔ Single quality system; single facility. ✔ Now - flexibility in encapsulation platforms! How can Aldevron advance your mRNA therapeutic or vaccine candidate?
Aldevron Announces Strategic Partnership with Acuitas Therapeutics
aldevron.com
To view or add a comment, sign in
-
Bringing mRNA therapeutics to patients requires an efficient and scalable downstream production process. A recent article explores the optimization of the mRNA capture step using advanced affinity resin technology. This approach aims to ensure a consistent purification platform, essential for advancing mRNA applications from development to clinical manufacturing. Read more: https://lnkd.in/g9H7JtXd #purification #mRNA #vaccines #biomanufacturing #bioprocessing #processdevelopment #lifesciences
Process optimization of mRNA purification for vaccines and therapeutic applications
insights.bio
To view or add a comment, sign in
-
Bringing mRNA therapeutics to patients requires an efficient and scalable downstream production process. A recent article explores the optimization of the mRNA capture step using advanced affinity resin technology. This approach aims to ensure a consistent purification platform, essential for advancing mRNA applications from development to clinical manufacturing. Read more: https://lnkd.in/g9H7JtXd #purification #mRNA #vaccines #biomanufacturing #bioprocessing #processdevelopment #lifesciences
Process optimization of mRNA purification for vaccines and therapeutic applications
insights.bio
To view or add a comment, sign in
-
Bringing mRNA therapeutics to patients requires an efficient and scalable downstream production process. A recent article explores the optimization of the mRNA capture step using advanced affinity resin technology. This approach aims to ensure a consistent purification platform, essential for advancing mRNA applications from development to clinical manufacturing. Read more: https://lnkd.in/g9H7JtXd #purification #mRNA #vaccines #biomanufacturing #bioprocessing #processdevelopment #lifesciences
Process optimization of mRNA purification for vaccines and therapeutic applications
insights.bio
To view or add a comment, sign in
-
Bringing mRNA therapeutics to patients requires an efficient and scalable downstream production process. A recent article explores the optimization of the mRNA capture step using advanced affinity resin technology. This approach aims to ensure a consistent purification platform, essential for advancing mRNA applications from development to clinical manufacturing. Read more: https://lnkd.in/g9H7JtXd #purification #mRNA #vaccines #biomanufacturing #bioprocessing #processdevelopment #lifesciences
Process optimization of mRNA purification for vaccines and therapeutic applications
insights.bio
To view or add a comment, sign in
-
Bringing mRNA therapeutics to patients requires an efficient and scalable downstream production process. A recent article explores the optimization of the mRNA capture step using advanced affinity resin technology. This approach aims to ensure a consistent purification platform, essential for advancing mRNA applications from development to clinical manufacturing. Read more: https://lnkd.in/g9H7JtXd #purification #mRNA #vaccines #biomanufacturing #bioprocessing #processdevelopment #lifesciences
Process optimization of mRNA purification for vaccines and therapeutic applications
insights.bio
To view or add a comment, sign in
-
Bringing mRNA therapeutics to patients requires an efficient and scalable downstream production process. A recent article explores the optimization of the mRNA capture step using advanced affinity resin technology. This approach aims to ensure a consistent purification platform, essential for advancing mRNA applications from development to clinical manufacturing. Read more: https://lnkd.in/g9H7JtXd #purification #mRNA #vaccines #biomanufacturing #bioprocessing #processdevelopment #lifesciences
Process optimization of mRNA purification for vaccines and therapeutic applications
insights.bio
To view or add a comment, sign in
-
Bringing mRNA therapeutics to patients requires an efficient and scalable downstream production process. A recent article explores the optimization of the mRNA capture step using advanced affinity resin technology. This approach aims to ensure a consistent purification platform, essential for advancing mRNA applications from development to clinical manufacturing. Read more: https://lnkd.in/g9H7JtXd #purification #mRNA #vaccines #biomanufacturing #bioprocessing #processdevelopment #lifesciences
Process optimization of mRNA purification for vaccines and therapeutic applications
insights.bio
To view or add a comment, sign in
-
Bringing mRNA therapeutics to patients requires an efficient and scalable downstream production process. A recent article explores the optimization of the mRNA capture step using advanced affinity resin technology. This approach aims to ensure a consistent purification platform, essential for advancing mRNA applications from development to clinical manufacturing. Read more: https://lnkd.in/g9H7JtXd #purification #mRNA #vaccines #biomanufacturing #bioprocessing #processdevelopment #lifesciences
Process optimization of mRNA purification for vaccines and therapeutic applications
insights.bio
To view or add a comment, sign in
-
What's new in mRNA analytical development?🧪🔬 Following Genentech’s publication on mRNA impurities, and Pfizer’s paper on mRNA vaccine immunogenicity, the importance of optimized mRNA assay development, analytics and QC is ever prominent! Uniting these technical teams under one roof in February, the 4th mRNA Analytical Development & Quality Control Summit returns to further bolster your mRNA therapeutic and vaccine submissions. With new speakers, companies, and data lining the agenda for 2025, here's a snapshot of what's in store: 🔬 Unlock the regulatory perspective and expectations from mRNA-LNP drug product with first hand insights from the FDA! 🔬 Streamline method development through improved chromatography methodologies, sensitive dsRNA detection methods and cell-based assays with: Orna Therapeutics | Sail Biomedicines | Sanofi | Moderna | Abogen Biosciences 🔬 Accelerate method validation and qualification through phase-appropriate drug substance and product CQAs, including LNP formulation and novel cell-targeted delivery with: Zipcode Bio | BioNTech SE | Tessera Therapeutics | Genentech | Aera Therapeutics 🔬 Streamline method transfer through QC-friendly and GMP compliant methods and platforms to expedite regulatory submissions with: Pfizer | Omega Therapeutics Download the three-day program to see more: https://ter.li/05g5j7 #mRNA #RNA #AnalyticalDevelopment #CMC #Regulatory #dsRNA
To view or add a comment, sign in
-